Abstract:Objective: To evaluate the effects of adeno-associated virus (AAV) carrying hFⅧ by serotype 8 (AAV8/hFⅧ) on hemophilia A (HA) mice by gene therapy strategy. Methods: pAAV-CB-EGFP, pH22 (serotype 2) and pfΔ6 (adenovirus helper) were used to package AAV into HEK-293 cells in different conditions (ratios of cells to plasmids). The efficiency of transfection and infection were evaluated using immunofluorescence microscope to seek an optimized package condition. pAAV-TTR-hFⅧ, pH 28 (serotype 8) and pfΔ6 were applied to package AAV8/hFⅧ in HEK-293 cells using the optimized package condition. The purified AAV8/hFⅧ were intravenously injected into HA mice and the effects of gene therapy were estimated. Results: The efficiency of package was evaluated according to the amount and intensity of enhanced green fluorescent protein (EGFP) under immunofluorescence microscope. Four package conditions including 10 cm-dish to transfect 10 μg plasmids, 20 cm-dish to 20 μg, 30 μg and 40 μg plasmids were employed, and the condition of 20 cm-dish to transfect 20 μg plasmids reached the highest transfection efficiency at 24 h, 48 h and 72 h after transfection. The small scale AAV-EGFP was packaged using the optimized condition and an AAV crude extract was harvested by a freeze-thaw method. HEK-293 and 16095 cells were infected by the AAV crude extract, and the preferential infection efficiency was recognized in 16095 cells under immunofluorescence microscope. Then, AAV8/hFⅧ was packaged and purified based on the optimized transfection condition, and the high purity of AAV8/hFⅧ was detected by Western blot. Fractions of AAV8/hFⅧ at the dose of 8×10(12) vg/kg were injected into HA mice through tail vein, an eye-bleeding was performed at every two weeks, and the activity of FⅧ was measured by aPTT assay. Results showed that the activity of FⅧ maintained at the therapeutic level and lasted up to 12 weeks after injection. Conclusion: The purified AAV8/hFⅧ based on the optimized package condition could play a role in HA mice gene therapy, and the long-term therapeutic effects of AAV8/hFⅧ were observed in vivo.

[Recombinant Adeno-Associated Virus Type 8 Mediated Dual-Luciferase Gene Expression in Mouse].

The Glymphatic System Delivery Enhances the Transduction Efficiency of AAV1 to Brain Endothelial Cells in Adult Mice.

[Real Time Ex Vivo Detection and Dynamic Monitoring of in Vivo Expression of Secreted Luciferase Gene Injected by Hydrodynamic Method].

Enhancing Transgene Expression from Recombinant AAV8 Vectors in Different Tissues Using Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element

[Construction of a Dual-Luciferase Co-Expression Vector and Its Characteristics in Vitro and in Vivo].

Sustaining Expression of B Domain-Deleted Human Factor VIII Mediated by Using Lentiviral Vectors in NOD/SCID Mouse.

Expression and effect of recombinant adeno-associated virus vector-8 transduced green fluorescent protein gene into rat keratocytes

e0228 Transfection of recombinant adeno-associated virus serotype 9 to mouse heart in vivo and the effects on cardiac function

In vivo imaging system in detecting expression and distribution of replication-deficient adenovirus carrying luciferase in mice

Construction of a gengeral adeno-associated virus vector and GFP expression in rat NIH3T3 transduced by the rAAV vector

The Biodistribution of Replication-Defective Simian Adenovirus 1 Vector in a Mouse Model

Transduction of mouse retina by insect cell packaged recombinant adeno-associated virusess and their mutants via intravitreal injection

Tropisms of rAAV2, 6, 8, 9 serotypes for intravitreal injection in the mouse retina

Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System

Optimization of Transfection Mediated by Calcium Phosphate for Plasmid Raav-Lacz (recombinant Adeno-Associated Virus-Beta-galactosidase Reporter Gene) Production in Suspension-Cultured HEK-293 (human Embryonic Kidney 293) Cells.

Targeting transgene to the heart and liver with AAV9 by different promoters

Study of Adeno-Associtated Virus Serotype 8 Mediated Shrna Delivery and Function in Livers of Mice

Enhancement of Recombinant Adeno-Associated Virus Mediated Transgene Expression by Targeted Echo-Contrast Agent.

[Optimized AAV Package and Experimental Application of Recombinant AAV8/hFⅧ for Gene Therapy on Hemophilia A Mice].

Improvement in the suspension-culture production of recombinant adeno-associated virus-LacZ in HEK-293 cells using polyethyleneimine-DNA complexes in combination with hypothermic treatment.

GW26-e2201 Recombinant Adeno-Associated Virus Serotype 9 Transfection of Atherosclerosis Mice: Determination of the Optimal Expression Time in Vivo